Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,339
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,860
Class I recallsReasonable probability of serious health consequences
24,450
Class II recallsTemporary or medically reversible health consequences
2,901
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,095 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,739 recalls have been announced year to date.
  • Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
  • The highest complete period was Jun 2026 (300).
  • Oct 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,450
Class I9,860
Class III2,901
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,450
Class I9,860
Class III2,901
Not Yet Classified2

Showing 6,821–6,840 of 17,454 recalls

FDA Recall TerminatedTerminated: December 7, 2023Historical recordClass II

Testosterone Cypionate/Progesterone Injection, TESTOSTERONE CYP/PROGESTERONE [2ML] 200MG/2.5MG/ML INJECTABLE, For IM Use, 2 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0531-2

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Published
March 11, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 7, 2023Historical recordClass II

Testosterone Cypionate Injection, TESTOSTERONE CYP IN GRAPESEED OIL [1ML] 200 MG/ML INJECTABLE, For IM Use, 1 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0530-2

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Published
March 11, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 7, 2023Historical recordClass II

Testosterone Cypionate Injection,TESTOSTERONE CYP IN GRAPESEED OIL [10ML] 200 MG/ML INJECTABLE, For IM Use, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0530-1

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Published
March 11, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 7, 2023Historical recordClass II

Super MIC Injection, SUPER MIC* INJECTABLE, Vitamin Complex, For IM Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0234-3

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Published
March 11, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 7, 2023Historical recordClass II

Selenium Injection, SELENIUM 200MCG/ML INJECTABLE, For IV Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0227-3

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Published
March 11, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 7, 2023Historical recordClass II

Pyridoxine Hydrochloride Injection, PYRIDOXINE HCL 100 MG/ML INJECTABLE, For IV, IM Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0216-3

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Published
March 11, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 7, 2023Historical recordClass II

Iohexol (PF) Injection,OMNIPAQUE INJECTION [5ML] 300MG I/ML INJECTABLE, For IA Use, 5 mL Single Use Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-1413-5

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Published
March 11, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 7, 2023Historical recordClass II

Nicotinamide Adenine Dinucleotide (PF) Injection, NICOTINAMIDE ADENINE DINUCLEOTIDE (PF) 20 MG/ML INJECTABLE, For IV, IM Use, Refrigerate, 10 mL Single Use Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0336-1

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Published
March 11, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 7, 2023Historical recordClass II

Nicotinamide Adenine Dinucleotide (PF) Injection, NICOTINAMIDE ADENINE DINUCLEOTIDE (PF) 50 MG/ML INJECTABLE, For IV, IM Use, Refrigerate, 10 mL Single Use Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0306-1

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Published
March 11, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 7, 2023Historical recordClass II

Mitomycin-C (PF) Irrigation Solution, MITOMYCIN-C (PF) 0.5 MG/ML PF SYRINGE, For Intravesicular Use, Freeze, Cytoxic Agent, Preservative Free, Protect From Light, 80 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0812-8

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Published
March 11, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 7, 2023Historical recordClass II

MIC-PLUS Injection, Vitamin Complex, MIC-COMBO* 25MG/50MG/50MG/1MG/20MG/5MG/ML INJECTABLE, For IM Use, Refrigerate, Protect From Light, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0231-3

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Published
March 11, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 7, 2023Historical recordClass II

MIC-PLEX Injection, Vitamin Complex, MIC-COMBO* 25MG/50MG/50MG/1MG/20MG/5MG/ML INJECTABLE, For IM Use, Protect From Light, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0233-3

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Published
March 11, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 7, 2023Historical recordClass II

MIC-B12 Injection, MIC-B12 25MG/50MG/50MG/1MG/ML INJECTABLE, For IM Use, Refrigerate. Protect From Light, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0230-3

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Published
March 11, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 7, 2023Historical recordClass II

Methylprednisolone Acetate Injectable Suspension, METHYLPREDNISOLONE ACETATE [10ML] CMC 50 MG/ML INJ SUSP, For IM, IA Use, Shake Well, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0636-1

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Published
March 11, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 7, 2023Historical recordClass II

Methylprednisolone Acetate Injectable Suspension, METHYLPREDNISOLONE ACETATE [10ML] CMC 100 MG/ML INJ SUSP, For IM, IA Use, Shake Well, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0619-1

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Published
March 11, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 7, 2023Historical recordClass II

Methylprednisolone Acetate Injectable Suspension, METHYLPREDNISOLONE ACETATE (PF) CMC [2ML] 80 MG/ML INJ SUSP, For IM, IA Use, Shake Well, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0639-2

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Published
March 11, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 7, 2023Historical recordClass II

Methylprednisolone Acetate/Bupivacaine Hydrochloride Injectable Suspension, METHYLPRED ACETATE/BUPIVACAINE HCL [10ML] CMC 80MG/5MG/ML INJ SUSP, For IM, IA Use, Shake Well, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0624-1

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Published
March 11, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 7, 2023Historical recordClass II

Methylprednisolone Acetate/Bupivacaine Hydrochloride Injectable Suspension, METHYLPRED ACETATE/BUPIV [10ML] CMC 40MG/5MG/ML INJ SUSP, For IM, IA Use, Shake Well, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0623-1

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Published
March 11, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 7, 2023Historical recordClass II

Methylcobalamin Injection, METHYLCOBALAMIN 1 MG/ML INJECTABLE, For IV, IM, SC Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0331-3

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Published
March 11, 2020
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: December 7, 2023Historical recordClass II

Methylcobalamin Injection, METHYLCOBALAMIN [CD] 10MG/100MG/ML INJECTABLE, For IV, IM, SC Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0338-3

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Published
March 11, 2020
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.